HEALTHY LIFESTYLE / CLINICAL RESEARCH
Changes in plasma concentration of cell-free DNA in response to physical activity
More details
Hide details
1
Institute for Clinical and Experimental Medicine, Prague, Czech Republic
2
3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic
3
Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
4
Department of Rehabilitation and Sports Medicine, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
5
Department of Biomedical Technology, Faculty of Biomedical Engineering in Kladno, Czech Technical University in Prague, Czech Republic
Submission date: 2025-01-07
Final revision date: 2025-04-22
Acceptance date: 2025-06-01
Online publication date: 2025-06-22
Corresponding author
Michal Vrablík
3rd Department of
Internal Medicine
General University Hospital
1st Faculty of Medicine
Charles University
Prague, Czech Republic
Michal Tomčík
Institute of Rheumatology
and Department of
Rheumatology
1st Faculty of Medicine
Charles University
Prague, Czech Republic
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Plasma concentrations of cell-free DNA (cfDNA) serve as markers of overtraining or muscle injury. We examined whether nuclear (n) or mitochondrial (mt) cfDNA has potential as a marker of muscle burden or damage.
Material and methods:
Ten healthy, physically active volunteers (6 females, aged 27.1 ±6.8 years) performed a downhill running test. Samples for cfnDNA and cell-free mitochondrial DNA (cfmtDNA) analysis were collected before, 30 min, 1 h, and 14 days after the downhill run. CfnDNA and cfmtDNA (two markers for each) were analyzed using qPCR.
Results:
There was an extreme (~40-fold) increase in cfnDNA at the 30-min time-point against the baseline (p < 0.00001 for both markers), followed by a quick drop to baseline levels after 1 h after the end of the downhill run for all subjects. In contrast, plasma levels of cfmtDNA did not increase significantly (p = 0.27 and 0.12). It reflects the fact that in 6 subjects, the pattern was similar as for cfnDNA, but in 4 subjects a decrease of cfmtDNA concentration was observed at the 30-min time-point. These differences correlate with age, body mass index, and sex of the participants. Plasma cfnDNA significantly (p < 0.01 for all) correlated with concentrations of muscle damage markers such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LD), and chemokines MIP-1 and IP-10 (positive). No homogeneous correlation between cfmtDNA and biomarkers was detected.
Conclusions:
Our study confirmed the extreme release and clearance of cfnDNA in physically active subjects after strenuous exercise. In contrast, the trajectory of cfmtDNA concentrations seems to have much higher inter-individual variability than cfnDNA concentrations.
REFERENCES (36)
1.
Zhang K, Fu R, Liu R, Su Z. Circulating cell-free DNA-based multi-cancer early detection. Trends Cancer 2024; 10: 161-74.
2.
Carbone L, Cariati F, Sarno L, et al. Non-invasive prenatal testing: current perspectives and future challenges. Genes 2020; 12: 15.
3.
Agbor-Enoh S, Shah P, Tunc I, et al. Cell-free DNA to detect heart allograft acute rejection. Circulation 2021; 143: 1184-97.
4.
Vittori LN, Tarozzi A, Latessa PM. Circulating cell-free DNA in physical activities. Methods Mol Biol 2019; 1909: 183-97.
5.
Andreatta MV, Curty VM, Coutinho JVS, et al. Cell-Free DNA as an earlier predictor of exercise-induced performance decrement related to muscle damage. Int J Sports Physiol Perform 2018; 13: 953-6.
6.
Haller N, Helmig S, Taenny P, Petry J, Schmidt S, Simon P. Circulating, cell-free DNA as a marker for exercise load in intermittent sports. PLoS One 2018; 13: e0191915.
7.
Haller N, Ehlert T, Schmidt S, et al. Circulating, cell-free DNA for monitoring player load in professional football. Int J Sports Physiol Perform 2019; 14: 718-26.
8.
Sugasawa T, Fujita SI, Kuji T, et al. Dynamics of specific cfDNA fragments in the plasma of full marathon participants. Genes 2021; 12: 676.
9.
Gentles JA, Hornsby WG, Coniglio CL, et al. Cell free DNA as a marker of training status in weightlifters. Biol Sport 2017; 34: 287-94.
10.
Fatouros IG, Destouni A, Margonis K, et al. Cell-free plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining. Clin Chem 2006; 52: 1820-4.
11.
Hui L, Maron J, Gahan PB. Other body fluids as non-invasive sources of cell-free DNA/RNA. In: Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring. Gahan PB (ed.). Springer Netherlands, 2015; 295-323.
12.
Moss J, Magenheim J, Neiman D, et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun 2018; 9: 5068.
13.
de Miranda FS, Barauna VG, Dos Santos L, Costa G, Vassallo PF, Campos LCG. Properties and application of cell-free DNA as a clinical biomarker. Int J Mol Sci 2021; 22: 9110.
14.
Hummel EM, Hessas E, Müller S, et al. Cell-free DNA release under psychosocial and physical stress conditions. Transl Psychiatry 2018; 8: 236.
15.
Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol 2019; 4: 663-74.
16.
Granata C, Jamnick NA, Bishop DJ. training-induced changes in mitochondrial content and respiratory function in human skeletal muscle. Sports Med 2018; 48: 1809-28.
17.
Švec X, Štorkánová H, Špiritović M, et al. Hsp90 as a myokine: Its association with systemic inflammation after exercise interventions in patients with myositis and healthy subjects. Int J Mol Sci 2022; 23: 11451.
18.
Štorkánová H, Oreská S, Špiritović M, et al. Hsp90 levels in idiopathic inflammatory myopathies and their association with muscle involvement and disease activity: a cross-sectional and longitudinal study. Front Immunol 2022; 13: 811045.
19.
Atamaniuk J, Stuhlmeier KM, Vidotto C, Tschan H, Dossenbach-Glaninger A, Mueller MM. Effects of ultra-marathon on circulating DNA and mRNA expression of pro- and anti-apoptotic genes in mononuclear cells. Eur J Appl Physiol 2008; 104: 711-7.
20.
Atamaniuk J, Vidotto C, Kinzlbauer M, Bachl N, Tiran B, Tschan H. Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise. Eur J Appl Physiol 2010; 110: 695-701.
21.
Breitbach S, Tug S, Simon P. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med 2012; 42: 565-86.
22.
Humińska-Lisowska K, Mieszkowski J, Kochanowicz A, et al. cfDNA changes in maximal exercises as a sport adaptation predictor. Genes (Basel) 2021; 12: 1238.
23.
Fridlich O, Peretz A, Fox-Fisher I, et al. Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes. Cell Rep Med 2023; 4: 101074.
24.
Mavropalias G, Calapre L, Morici M, et al. Changes in plasma hydroxyproline and plasma cell-free DNA concentrations after higher- versus lower-intensity eccentric cycling. Eur J Appl Physiol 2021; 121: 1087-97.
25.
Juškevičiūtė E, Neuberger E, Eimantas N, Heinkel K, Simon P, Brazaitis M. Cell-free DNA kinetics in response to muscle-damaging exercise: a drop jump study. Exp Physiol 2024; 109: 1341-52.
26.
Simmons JD, Lee YL, Mulekar S, et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg 2013; 258: 591‐6.
27.
Li J, Zhao B, Chen S, et al. Downhill running induced DNA damage enhances mitochondrial membrane permeability by facilitating ER-mitochondria signaling. J Muscle Res Cell Motil 2022; 43: 185-93.
28.
Robin ED, Wong R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol 1988; 136: 507-13.
29.
Okie JG, Smith VH, Martin-Cereceda M. Major evolutionary transitions of life, metabolic scaling and the number and size of mitochondria and chloroplasts. Proc Biol Sci 2016; 283: 20160611.
30.
Guantes R, Díaz-Colunga J, Iborra FJ. Mitochondria and the non-genetic origins of cell-to-cell variability: more is different. Bioessays 2016; 38: 64-76.
31.
MacInnis MJ, Gibala MJ. Physiological adaptations to interval training and the role of exercise intensity. J Physiol 2017; 595: 2915-30.
32.
Meddeb R, Dache ZAA, Thezenas S, et al. Quantifying circulating cell-free DNA in humans. Sci Rep 2019; 9: 5220.
33.
Beiter T, Fragasso A, Hudemann J, Niess AM, Simon P. Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo. Clin Chem 2011; 57: 633-6.
34.
Ohlsson L, Hall A, Lindahl H, et al. Increased level of circulating cell-free mitochondrial DNA due to a single bout of strenuous physical exercise. Eur J Appl Physiol 2020; 120: 897-905.
35.
Helmig S, Fruhbeis C, Kramer-Albers EM, Simon P, Tug S. Release of bulk cell free DNA during physical exercise occurs independent of extracellular vesicles. Eur J Appl Physiol 2015; 115: 2271-80.
36.
Shockett PE, Khanal J, Sitaula A, et al. Plasma cell-free mitochondrial DNA declines in response to prolonged moderate aerobic exercise. Physiol Rep 2016; 4: e12672.